Oduncuoğlu Bahar Füsun, Alaaddinoğlu Emine Elif, Çolak Turan, Akdur Aydıncan, Haberal Mehmet
Department of Periodontology, Faculty of Dentistry, Başkent University, Ankara, Turkey.
Department of Nephrology, Faculty of Medicine, Başkent University, Ankara, Turkey.
Transplant Proc. 2020 Apr;52(3):785-792. doi: 10.1016/j.transproceed.2020.01.016. Epub 2020 Feb 27.
Patients with end-stage renal disease have a lower quality of life compared to the general population. Oral health-related quality of life (OHRQoL) is of particular interest as good oral health could influence general health. This study aimed to compare dental and periodontal health status, OHRQoL, and general health perception of renal transplant (TX) and hemodialysis patients (HD) with that of healthy controls.
The study included 64 TX, 63 HD, and 61 healthy patients. TX patients were also grouped according to the time elapsed after transplantation and currently use of immunosuppressive agents. The numbers of decayed, missing, and filled teeth were recorded as DMFT, and periodontal health status was evaluated. Patients' general health perceptions and OHRQoL were assessed using Short Form-36, Oral Health Impact Profile-14, and OHRQoL-United Kingdom questionnaires.
The HD groups presented significantly higher DMFT scores and periodontal scores than TX and control groups. OHRQoL-United Kingdom total scores of TX and HD groups were lower than controls (P < .05). Oral Health Impact Profile-14 total scores revealed that HD groups' OHRQoL was significantly lower than TX and control groups (P < .05). Perceptions of general health of TX patients were higher than in the HD group.
Renal transplantation has shown to increase quality of life and OHRQoL compared to hemodialysis therapy. Neither the immunosuppressive agent nor the time elapsed after transplantation were observed to be significant factors affecting OHRQoL.
与普通人群相比,终末期肾病患者的生活质量较低。口腔健康相关生活质量(OHRQoL)尤其受到关注,因为良好的口腔健康可能会影响整体健康。本研究旨在比较肾移植(TX)患者、血液透析患者(HD)与健康对照者的牙齿和牙周健康状况、OHRQoL及整体健康认知。
该研究纳入了64例肾移植患者、63例血液透析患者和61例健康患者。肾移植患者还根据移植后经过的时间以及目前免疫抑制剂的使用情况进行分组。记录龋、失、补牙数作为DMFT,并评估牙周健康状况。使用简明健康调查问卷(Short Form-36)、口腔健康影响程度量表-14(Oral Health Impact Profile-14)和英国口腔健康相关生活质量问卷(OHRQoL-United Kingdom)评估患者的整体健康认知和OHRQoL。
血液透析组的DMFT评分和牙周评分显著高于肾移植组和对照组。肾移植组和血液透析组的英国口腔健康相关生活质量问卷总分低于对照组(P < .05)。口腔健康影响程度量表-14总分显示,血液透析组的OHRQoL显著低于肾移植组和对照组(P < .05)。肾移植患者的整体健康认知高于血液透析组。
与血液透析治疗相比,肾移植已显示出能提高生活质量和OHRQoL。未观察到免疫抑制剂和移植后经过的时间是影响OHRQoL的显著因素。